FAU REPORT: Consumers Face Elevated Prices Despite Waning Inflation
The years of high inflation appear to be over as inflation is now in line with the Federal Reserve’s target, though prices will likely remain permanently elevated, according to the Monthly Inflation Report produced by Florida Atlantic University’s College of Business.
The years of high inflation appear to be over as inflation is now in line with the Federal Reserve’s target, though prices will likely remain permanently elevated, according to the Monthly Inflation Report produced by Florida Atlantic University’s College of Business.
The Personal Consumption Expenditures Price Index (PCEPI), the Federal Reserve’s preferred measure of inflation, grew at a continuously compounding annual rate of 2.1% in September, up from 1.4% the prior month. Overall, PCEPI inflation has averaged 1.8% over the last three months and 2.1% over the last year.
“The good news is that the period of high inflation appears to be in the rearview mirror. The bad news is that prices remain permanently elevated,” said William J. Luther, Ph.D., associate professor of economics in FAU’s College of Business. “The PCEPI is about nine percentage points higher today than it would have been had inflation averaged 2% since January 2020. This unexpected burst of inflation transferred wealth from savers and employees to borrowers and employers.”
Core inflation, which excludes volatile food and energy prices, remains elevated. Core PCEPI grew at a continuously compounding annual rate of 3% in September. It has averaged 2.3% over the last three months and 2.6% over the last year. High core inflation is partly due to housing services prices, which grew at a continuously compounding annual rate of 3.8% in September.
“If the Fed were committed to price stability, it would have helped bring prices back down to a level consistent with pre-pandemic inflation,” Luther said.
Fed officials have projected another 25 basis points worth of rate cuts this year, a much smaller change than is required to return the policy rate to neutral. Since the data shows inflation is back on track, Luther says they should move more quickly.
“As it stands, Federal Open Market Committee members intend to take some time reducing the policy rate to neutral, with policy likely to return to neutral sometime in 2026,” Luther said. “They might move more quickly if the economy shows signs of contraction or reduce the pace of rate cuts if they become concerned that inflation will pick back up.”
-FAU-
Latest Research
- FAU Receives $1M Grant to Study Gulf's Mesophotic Coral HabitatsFAU Harbor Branch researchers and collaborators will study how ocean currents and river nutrients affect deep coral ecosystems on the West Florida Shelf - one of the gulf's largest and least-studied habitats.
- Survey: Tariff Uncertainty Worries Port Everglades BusinessesThe Port Everglades business ecosystem is facing a year of labor challenges and growing concerns over tariff uncertainty, according to a survey from a supply chain management professor at FAU.
- AI Reveals Astrocytes Play a 'Starring' Role in Dynamic Brain FunctionA new FAU study shows astrocytes help neurons fire in sync, shaping brain rhythms key for attention, memory and sleep - guiding how groups of neurons work together during high-focus or restful states.
- FAU Researcher to Make Big 'Splash' in NatGeo's SharkFestShark fanatics, science buffs and ocean advocates won't want to miss a thrilling new episode of NatGeo's "Florida's Bite Capital," with FAU professor Stephen Kajiura, Ph.D. on National Geographic.
- FAU's Paulina DeVito Awarded Elite NSF Graduate Research FellowshipPaulina DeVito, 22, a Ph.D. candidate in FAU's College of Engineering and Computer Science, has been awarded a prestigious National Science Foundation fellowship for her exemplary work in AI and education.
- Hope for Brain Cancer: FAU Awarded Grants for Glioblastoma TreatmentFAU researchers are pioneering a new approach to treating glioblastoma - a highly aggressive brain cancer with one of the highest mortality rates - by targeting the gene MBLAC1 for the first time.